XHKG
0775
Market cap636mUSD
Oct 09, Last price
0.52HKD
1D
0.00%
1Q
-11.86%
Jan 2017
-24.64%
IPO
-72.18%
Name
CK Life Sciences Intl (Holdings) Inc
Chart & performance
P/E
—
P/S
0.92
EPS
—
Div yield, %
—
Shrs. gr., 5y
0.04%
Rev. gr., 5y
1.82%
Revenues
5.41b
-2.04%
Net income
-188m
L+48.91%
CFO
-33m
L
Dividend
May 23, 20230.008 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related and Health. The company was founded on August 10, 2001 and is headquartered in Hong Kong.
Key people
Executive Chairman of the Board · since 2002
President, Executive Director · since 2020
Yiu Leung Mo
Chief Financial Officer · since 2020
Angus Barrington-Case
Chief Executive Officer of Regenal Investments Pty Limited · since 2020
Patrick Brueggman
President, Chief Executive Officer of Vitaquest International LLC
Mark Herron
Chief Executive Officer of Australian Agribusiness Holdings Pty Limited · since 2020
Andrew Speed
Chief Executive Officer of the Cheetham Salt Group
Rob Tanna
Chief Executive Officer of Lipa Pharmaceuticals Limited
Philippe Trudeau
President, Chief Executive Officer of Sante Naturelle Adrien Gagnon Limited
Vice President - Finance · since 2020
Pak To Wu
Vice President - Global Operations · since 2020
Kean Meng Toh
Chief Scientific Officer, Vice President, Executive Director · since 2018
Lee Yuen
Chief Executive Officer, Vice President, Executive Director · since 2024
King Sang Hon
Legal Counsel
Senior Vice President, Chief Investment Officer, Executive Director
Ying Choi Yu
Deputy Chairman of the Board, Executive Director · since 2024
Fu Lam Ha
Business Development Director · since 2020
Wai Man Ho
Business Development Director · since 2011
Yuen Man Ko
General Manager of Vital Care Hong Kong Limited · since 2020
Walter Korz
Chief Operating Officer of WEX Pharmaceuticals Inc · since 2020
IPO date
Jul 16, 2002
Employees
1,887
Domiciled in
HK
Incorporated in
KY
Headquarters & legal address
c/o MAPLES CORPORATE SERVICES LIMITED, Ugland House, South Church Street, P. O. Box 309
George Town KY1-1104
KY
George Town KY1-1104
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||